These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 33245136)

  • 41. Is loss of sense of smell a diagnostic marker in COVID-19: A systematic review and meta-analysis.
    Rocke J; Hopkins C; Philpott C; Kumar N
    Clin Otolaryngol; 2020 Nov; 45(6):914-922. PubMed ID: 32741085
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Subjective Smell Disturbances in Children with Sars-Cov-2 or Other Viral Infections do not Correspond with Olfactory Test Results.
    Grote H; Hoffmann A; Kerzel S; Lukasik H; Maier C; Mallon C; Schlegtendal A; Schwarzbach M; van Ackeren K; Volkenstein S; Brinkmann F
    Klin Padiatr; 2024 Feb; 236(2):129-138. PubMed ID: 38262421
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of olfactory dysfunction persistence after COVID-19: a prospective study.
    Bianco MR; Ralli M; Minni A; Greco A; de Vincentiis M; Allegra E
    Eur Rev Med Pharmacol Sci; 2022 Feb; 26(3):1042-1048. PubMed ID: 35179771
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Objective evaluation of odor loss in COVID-19 and other suspected cases.
    Seden N; Yiğit E; Yiğit Ö; Kaygısız İ
    Am J Otolaryngol; 2021; 42(1):102761. PubMed ID: 33080550
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk Factors for Olfactory and Gustatory Dysfunctions in Patients with SARS-CoV-2 Infection.
    Galluzzi F; Rossi V; Bosetti C; Garavello W
    Neuroepidemiology; 2021; 55(2):154-161. PubMed ID: 33794531
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A 32-Year-Old Man with Persistent Olfactory Dysfunction Following COVID-19 Whose Recovery Was Evaluated by Retronasal Olfactory Testing.
    Hirano K; Tanaka Y; Kamimura S; Suzaki I; Suzuki E; Kobayashi H
    Am J Case Rep; 2022 Sep; 23():e936496. PubMed ID: 36089753
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Proof-of-concept: SCENTinel 1.1 rapidly discriminates COVID-19-related olfactory disorders.
    Hunter SR; Hannum ME; Pellegrino R; O'Leary MA; Rawson NE; Reed DR; Dalton PH; Parma V
    Chem Senses; 2023 Jan; 48():. PubMed ID: 36796784
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Psychophysical evaluation of chemosensory functions 5 weeks after olfactory loss due to COVID-19: a prospective cohort study on 72 patients.
    Le Bon SD; Pisarski N; Verbeke J; Prunier L; Cavelier G; Thill MP; Rodriguez A; Dequanter D; Lechien JR; Le Bon O; Hummel T; Horoi M
    Eur Arch Otorhinolaryngol; 2021 Jan; 278(1):101-108. PubMed ID: 32754871
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Olfactory epithelium histopathological findings in long-term coronavirus disease 2019 related anosmia.
    Vaira LA; Hopkins C; Sandison A; Manca A; Machouchas N; Turilli D; Lechien JR; Barillari MR; Salzano G; Cossu A; Saussez S; De Riu G
    J Laryngol Otol; 2020 Dec; 134(12):1123-1127. PubMed ID: 33190655
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Smell and Taste Dysfunction in Pediatric Patients With SARS-CoV-2 Infection.
    Púa Torrejón RC; Ordoño Saiz MV; González Alguacil E; Furones García M; Cantarín Extremera V; Ruiz Falcó ML; Soto Insuga V
    Pediatr Neurol; 2022 Nov; 136():28-33. PubMed ID: 36084419
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long COVID, audiovestibular symptoms and persistent chemosensory dysfunction: a systematic review of the current evidence.
    De Luca P; Di Stadio A; Colacurcio V; Marra P; Scarpa A; Ricciardiello F; Cassandro C; Camaioni A; Cassandro E
    Acta Otorhinolaryngol Ital; 2022 Apr; 42(Suppl. 1):S87-S93. PubMed ID: 35763279
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Olfactory dysfunction at six months after coronavirus disease 2019 infection.
    Leedman SR; Sheeraz M; Sanfilippo PG; Edgar DW; D'Aulerio GV; Robb DM; Richards T; Blyth CC; Mackey DA
    J Laryngol Otol; 2021 Sep; 135(9):839-843. PubMed ID: 34348821
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnosed and subjectively perceived long-term effects of COVID-19 infection on olfactory function assessed by supervised machine learning.
    Lötsch J; Brosig O; Slobodova J; Kringel D; Haehner A; Hummel T
    Chem Senses; 2024 Jan; 49():. PubMed ID: 38213039
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sudden onset, acute loss of taste and smell in coronavirus disease 2019 (COVID-19): a systematic review.
    Samaranayake LP; Fakhruddin KS; Panduwawala C
    Acta Odontol Scand; 2020 Aug; 78(6):467-473. PubMed ID: 32762282
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A tool for the psychophysical assessment of olfactory dysfunction in patients with COVID-19.
    Kim KS; Min HJ
    Ear Nose Throat J; 2024 Jun; 103(1_suppl):102S-104S. PubMed ID: 35348400
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical significance of olfactory dysfunction in patients of COVID-19.
    Chang CC; Yang MH; Chang SM; Hsieh YJ; Lee CH; Chen YA; Yuan CH; Chen YL; Ho SY; Tyan YC
    J Chin Med Assoc; 2021 Jul; 84(7):682-689. PubMed ID: 34074933
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy and safety of oral corticosteroids and olfactory training in the management of COVID-19-related loss of smell.
    Le Bon SD; Konopnicki D; Pisarski N; Prunier L; Lechien JR; Horoi M
    Eur Arch Otorhinolaryngol; 2021 Aug; 278(8):3113-3117. PubMed ID: 33423106
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mechanistic Understanding of the Olfactory Neuroepithelium Involvement Leading to Short-Term Anosmia in COVID-19 Using the Adverse Outcome Pathway Framework.
    Shahbaz MA; De Bernardi F; Alatalo A; Sachana M; Clerbaux LA; Muñoz A; Parvatam S; Landesmann B; Kanninen KM; Coecke S
    Cells; 2022 Sep; 11(19):. PubMed ID: 36230989
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Olfactory-related Quality of Life Adjustments in Smell Loss during the Coronavirus-19 Pandemic.
    Liu DT; Prem B; Besser G; Renner B; Mueller CA
    Am J Rhinol Allergy; 2022 Mar; 36(2):253-260. PubMed ID: 34704454
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Younger adults with mild-to-moderate COVID-19 exhibited more prevalent olfactory dysfunction in Taiwan.
    Cheng MY; Hsih WH; Ho MW; Lai YC; Liao WC; Chen CY; Chen TC; Lee YL; Liu PY; Kao CC; Chou CH; Lin PC; Chi CY; Leong LY; Tai CJ; Lu MC
    J Microbiol Immunol Infect; 2021 Oct; 54(5):794-800. PubMed ID: 33610511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.